SCHEMBL7956909

SCHEMBL7956909

FC(c1ccc(Br)cc1)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.40
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
HTR2A P28223 1/20 0.35
CYP1A2 P05177 2/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA5A P35218 1/20 0.34
CA9 Q16790 1/20 0.34
CTSL P07711 2/20 0.34
CTSB P07858 2/20 0.34
CTSS P25774 2/20 0.34
CTSK P43235 2/20 0.34
ALDH1A1 P00352 3/20 0.32
ALOX15 P16050 2/20 0.32
MAPK1 P28482 1/20 0.32
CYP19A1 P11511 1/20 0.31
DPP4 P27487 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL15572800 0.83 KDM1A (0.33) HTR2ACA1CA2CA5ACA9
SCHEMBL6516945 0.81 CYP2A6 (0.36) CYP2A6ESR1ESR2HTR2ACYP1A2
SCHEMBL30204365 0.79 ESR1 (0.39) ESR1ESR2MAPK1HPGD
SCHEMBL1877826 0.77 CYP2A6 (0.42) CYP2A6ESR1ESR2HTR2ACYP1A2
SCHEMBL9340573 0.76 CYP2A6 (0.32) CYP2A6HTR2A
SCHEMBL12611448 0.75 TSHR (0.52) CYP2A6ESR1ESR2ALDH1A1MAPK1
SCHEMBL17490848 0.75 CHRNA7 (0.41) ESR1ESR2CA1CA2CA5A
SCHEMBL28477107 0.75 CYP2A6 (0.40) CYP2A6ESR1ESR2HTR2ACYP1A2
SCHEMBL7772037 0.74 DPP4 (0.39) HTR2AALDH1A1DPP4CYP2D6
SCHEMBL15575588 0.73 CYP2A6 (0.38) CYP2A6ESR1ESR2HTR2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024008909-A1 INHIBITORS OF CORONAVIRUS JANSSEN PHARMACEUTICA NV (BE) 2024-01-11 WO disclosed
CN-1220666-C Monomer containing electron drawing group and electron donating group and polymer and proton conductive membrane containing same JSR CORP (JP) 2005-09-28 CN disclosed
CN-1379009-A Monomer containing electron drawing group and electron donating group and polymer and proton conductive membrane containing same JSR CORP (JP) 2002-11-13 CN disclosed
US-6271248-B1 USED IN TREATING HYPERTENSION, PULMONARY HYPERTENSION, RENAL/ GLOMERULAR/MESANGIAL CELL DISORDERS, ENDOTOXEMIA, ISCHEMIA, TUMOR GROWTH, ATHERSCLEROSIS, RESTENOSIS, SUBARACHNOID HEMORRHAGE, PROSTATIC HYPERTROPHY, CONGESTIVE HEART FAILURE BRISTOL-MYERS SQUIBB COMPANY 2001-08-07 US disclosed
US-6080774-A Substituted biphenylsulfonamide endothelin antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2000-06-27 US disclosed
EP-0768305-A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 1997-04-16 EP disclosed